:back to venture 2005 page
:affinergy: biological glues
featured firm!

Affinergy , Inc. (RTP, NC  www.affinergy.com) develops "biological glues" for controlling biology at the convergence of therapeutics and medical devices. Their primary market is the $14 billion orthopedic market. By controlling delivery of various growth factors such as BMP and cell types (stem cells, osteoblasts ), Affinergy improves integration of devices into the body, reduces healthcare costs and improves patient outcomes.

[ home ]
:sig interviews 2005 venture firms

on his "successtoday" program, famous business interviewer sig hutchinson talks with leaders from the 10 tech companies (menu listed at right) selected to present at the ced's 2005 venture event in pinehurst, nc.

the firms talk about their unique technologies, business strategies, and some of their plans for the future.

:sig interviews 2005 venture firms

on his "successtoday" program, famous business interviewer sig hutchinson talks with leaders from the 10 tech companies (menu listed at right) selected to present at the ced's 2005 venture event in pinehurst, nc.

the firms talk about their unique technologies, business strategies, and some of their plans for the future.

[ home ]
this venture 2005 series has been brought to you by these sponsors:
:the research triangle's tv station
:viewers in 79 countries and counting
:affinergy: biological glues
featured firm!

Affinergy , Inc. (RTP, NC  www.affinergy.com) develops "biological glues" for controlling biology at the convergence of therapeutics and medical devices. Their primary market is the $14 billion orthopedic market. By controlling delivery of various growth factors such as BMP and cell types (stem cells, osteoblasts ), Affinergy improves integration of devices into the body, reduces healthcare costs and improves patient outcomes.

:back to venture 2005 page